A robust Bayesian dose optimization design with backfill and randomization for phase I/II clinical trials
{{output}}
The integration of backfill cohorts into Phase I clinical trials has garnered increasing interest within the clinical community, particularly following the "Project Optimus" initiative by the U.S. Food and Drug Administration, as detailed in their final guid... ...
